Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Docetaxel

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

79 API Suppliers, 40 USDMF, 28 CEP/COS, 10 JDMF, 8 EU WC, 14 KDMF, 15 NDC API, 40 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

88 Drugs in Development

88 Drugs in Development

INTERMEDIATES

14 Intermediate Suppliers

14 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

296 FDF Dossiers, 85 FDA Orange Book, 99 Europe, 4 Canada, 8 Australia, 31 South Africa, 69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 20MG/0.5ML (40MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 80MG/2ML (40MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 20MG/VIAL, INJECTABLE;INJECTION - 80MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Boai NKY Pharmaceuticals Ltd, 3 Nanjing Well Pharmaceutical, 2 Actylis, 2 BASF, 1 Clariant, 1 Finar, 3 Gangwal Chemicals, 1 Nanjing Bold Chemical, 6 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Solubilizers, 7 Parenteral, 7 Topical, 4 Film Formers & Plasticizers, 4 Emulsifying Agents, 4 Thickeners and Stabilizers, 3 Surfactant & Foaming Agents, 2 Rheology Modifiers, 1 Co-Processed Excipients, 1 Direct Compression, 1 Coating Systems & Additives, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 132 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 55 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

13 APIs, 14 FDF Dossiers

PATENTS & EXCLUSIVITIES

44 US Patents, 10 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 USP, 4 JP, 16 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/03/2025	Phyton Biotech LLC	Canada	Sampoong Pharmachem Co., Ltd.	20200421-210-J-608	Docetaxel	2020-04-21	Phyton Biotech LLC	Canada	1527 Cliveden Avenue, Delta, British Columbia, V3M6P7, Canada
28/03/2025	EUROAPI	France	Sanofi-Aventis Korea Co., Ltd.	20230607-210-J-1506	Docetaxel trihydrate	2023-06-07	Sanofi Winthrop Industrie	France	9, quai Jules Guesde, Vitry-sur-Seine, 94403, France

Docetaxel

Docetaxel

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

79 API Suppliers

40 USDMF

28 CEP/COS

10 JDMF

8 EU WC

14 KDMF

15 NDC API

40 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

88 Drugs in Development

INTERMEDIATES

14 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

296 FDF Dossiers

85 FDA Orange Book

99 Europe

4 Canada

8 Australia

31 South Africa

69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/0.5ML (40MG/ML)

INJECTABLE;INJECTION - 80MG/4ML (20MG/ML)

INJECTABLE;INJECTION - 80MG/2ML (40MG/ML)

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/ML (20MG/ML)

INJECTABLE;INJECTION - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 80MG/4ML (20MG/ML)

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/ML (20MG/ML)

INJECTABLE;INJECTION - 80MG/4ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/VIAL

INJECTABLE;INJECTION - 80MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Boai NKY Pharmaceuticals Ltd

3 Nanjing Well Pharmaceutical

2 Actylis

2 BASF

1 Clariant

1 Finar

3 Gangwal Chemicals

1 Nanjing Bold Chemical

6 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Solubilizers

7 Parenteral

7 Topical

4 Film Formers & Plasticizers

4 Emulsifying Agents

4 Thickeners and Stabilizers

3 Surfactant & Foaming Agents

2 Rheology Modifiers

1 Co-Processed Excipients

1 Direct Compression

1 Coating Systems & Additives

1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

1 Stock Recap #PipelineProspector

132 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

55 Regulatory FDF Prices

7 Annual Reports

MARKET PLACE

13 APIs

14 FDF Dossiers

PATENTS & EXCLUSIVITIES

44 US Patents

INJECTABLE;INJECTION - 40MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons